Vaxxa AB reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 27.76 million compared to SEK 15.05 million a year ago. Revenue was SEK 27.93 million compared to SEK 15.29 million a year ago. Net loss was SEK 0.327 million compared to SEK 33.5 million a year ago. Basic loss per share from continuing operations was SEK 0.01 compared to SEK 18 a year ago.
For the full year, sales was SEK 54.93 million compared to SEK 45.68 million a year ago. Revenue was SEK 55.64 million compared to SEK 46.85 million a year ago. Net loss was SEK 5.1 million compared to SEK 51.12 million a year ago. Basic loss per share from continuing operations was SEK 0.2 compared to SEK 28 a year ago.